Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Fazer Bakery’s tasty new products for the spring – many ways to enjoy wholegrain and cakes that are ready to serve after defrosting

At the end of January, delicious new flavours will take over shops across the country, when Fazer Bakery is launching a variety of fibre-rich and tasty breads. The novelty selection also includes gluten-free Reissumies, gorgeous Pullava buttery buns and mouth-watering cakes made from Fazer’s sweets Pätkis and Fazerina. The in-store bake-off units will have a new, cheesy snack.Fazer Puikula Kuiturikas Kaura (fibre-rich oat bread) 6 pcs 330 g The porridge that forms the basis of the bread dough gives the bread a soft and rich structure that feels fresh for several days. In addition to its

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseJanuary 24, 2024 at 9.30 am EETRepurchase of Outokumpu’s own shares On January 23, 2024, Outokumpu has completed repurchases of its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|CEUX |96,232 |3.9647

Medivir to present at the Redeye Fight Cancer Day

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the Redeye Fight Cancer Day, today January 24, 2024.   CEO Jens Lindberg will present the company and updated data from the ongoing phase 1b/2a clinical study with fostroxacitabine bralpamide (fostrox) at 15.20 CET. The presentation is live broadcasted and can be followed at the event page; https://www.redeye.se/events/966280/redeye-theme-fight-cancer-2

Quarterly Report I 23/24

September 2023 – November 2023, Diamyd Medical AB (publ), Fiscal year 2023/2024Precision Medicine for Autoimmune Diabetes in Pivotal Phase 3Diamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B.Further information is available on https://www.diamyd.com September 1, 2023 – November 30, 2023 · Operating income: MSEK 1.0 (1.0) · Net result: MSEK -32.8 (-33.0) · Result per share: SEK -0.4 (-0.4) · Cash flow from operating activities: MSEK -27.8 (-27.1) · Cash and short-term investments at November 30, 2023: MSEK 176.7 (130.9)

Invitation to a press and analyst conference in Stockholm for the presentation of Concentric’s Fourth Quarter 2023 results

Concentric's Interim Report for Q4 2023 (January-December 2023), will be published on the 7th of February  2024, at 08.00 CET. At 10.00 CET media, investors and analysts are invited to Tändstickspalatset, Västra Trädgårdsgatan 15 in Stockholm, for a presentation of the report. There will also be an opportunity to participate via webcast/telephone conference. President & CEO Martin Kunz and CFO Marcus Whitehouse will host the presentation, which will be held in English and is followed by a Q&A-session. We look forward to your participation. Please see the below detailed information to

Flagship Biosciences and Offspring Biosciences Partner to Provide Complete Global Assay Development Services from Target Identification to Companion Diagnostics

Unlocking the combined value of Offspring’s innovative pre-clinical solutions with Flagship’s clinical trial data-driven assay solutions Broomfield, CO, USA and Södertälje, Sweden – January 24, 2024 – Flagship Biosciences, a leader in spatial biology and biomarker analytics services, and Offspring Biosciences, an innovator in pre-clinical biomarker assay solutions, today announced a strategic partnership that aims to further advance precision drug development with a complete biomarker offering from discovery to companion diagnostics development.The partnership allows both companies to

Handelsbanken’s year-end report for January – December 2023 will be presented Wednesday 7 February

Handelsbanken publishes its year-end report for January ­– December 2023, at 07:00 a.m. CET Wednesday, 7 February. The report, slide presentation and Fact Book will be published on handelsbanken.com/ir. The President and Group Chief Executive Officer Michael Green will present the year-end report at 09:00 a.m. CET. The presentation will be broadcast live in Swedish and available at handelsbanken.com/ir and with the option for simultaneous interpretation into English. The presentation will be followed by a short break, after which a Q&A session will be held in English for analysts,

Equity Issuance

For Immediate Release 24 January 2024 ROGUE BARON PLC (“Rogue Baron” or “the Company”) Equity Issuance Rogue Baron PLC (AQSE: SHNJ), a leading company in the premium spirit sector, announces that it has issued 3,928,571 ordinary shares to certain consultants and creditors of the Company. Admission to Aquis Growth Market Application will be made for the 3,928,571 new ordinary shares to be admitted to trading on the Aquis Growth Market ("Admission"). It is expected that Admission of the new ordinary shares will become effective at 8.00 a.m. on or around 29 January 2024.

Storytel sharpens focus on profitability on the back of strong Q4 2023 earnings and upgrades mid-term financial targets - announces efficiency initiative and write-downs

· Storytel sharpens its focus on profitability and will improve cash flow generation beyond the previously outlined guidance at the Capital Markets Day in June 2023. An efficiency optimization initiative will be implemented during the first quarter of 2024, including a 13% reduction in workforce.   · As a result of increased emphasis on profitability and reduced growth investments in certain markets, related assets will not generate as much cash flow as previously planned. For that reason a non-cash write down of 632 MSEK will be recorded in the fourth quarter of 2023. 465 MSEK of the

Proposal of the Shareholders’ Nomination Board for the composition and remuneration of Tokmanni Group’s Board of Directors

Tokmanni Group Corporation        Stock exchange release        24 January 2024 at 9:00 amThe Shareholders’ Nomination Board of Tokmanni Group Corporation proposes to the Annual General Meeting that the number of the members of the Board of Directors remains the same and be six. The Nomination Board proposes that the current members of the Board of Directors Seppo Saastamoinen, Harri Sivula, Erkki Järvinen, Ulla Serlenius and Mikko Bergman will be re-elected. The Nomination Board also proposes that Eja Tuominen will be elected as a new member to the Board of Directors. Current Member of

Inside Information: Changes in Bittium Corporation’s Management Group

Bittium CorporationInside information Inside Information: Changes in Bittium Corporation’s Management Group Bittium Corporation, Stock Exchange Release, January 24, 2024, at 9:00 am (CET+1) Antti Näykki, Senior Vice President, Medical Business Segment, Bittium Corporation (Engineer, Embedded Systems) has been appointed as Vice President, Group Business Development as of February 1, 2024. He will continue as a member of Bittium Corporation's management group. In this role, Näykki will focus on building Bittium's long-term growth. He will also be responsible for the management of

Expert Tips for 2 weeks guide in Thailand

The Tourism Authority of Thailand's Stockholm office was delighted to engage in an insightful discussion with Towe Ahlin from Come Fly with Me , an experienced travel blogger, to uncover the secrets to Thai adventure. With her numerous travels across Thailand, Towe's knowledge and recommendations are invaluable for anyone seeking a meaningful experience in Thailand. Our goal is to ensure that every traveler embarks on a journey that surpasses their expectations whether you're a first-time visitor or regular Thailand’s explorer.When is a good time to travel to

Expert Tips for 2 weeks guide in Thailand

The Tourism Authority of Thailand's Stockholm office was delighted to engage in an insightful discussion with Towe Ahlin from Come Fly with Me , an experienced travel blogger, to uncover the secrets to Thai adventure. With her numerous travels across Thailand, Towe's knowledge and recommendations are invaluable for anyone seeking a meaningful experience in Thailand. Our goal is to ensure that every traveler embarks on a journey that surpasses their expectations whether you're a first-time visitor or regular Thailand’s explorer.When is a good time to travel to

Transaction in Own Shares

    24 January 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |23/01/2024|+-----------------------------------------------------------

WntResearch's co-founder applies for subscription of additional units in the ongoing rights issue with a last day for subscription on 29 January 2024

Tommy Andersson, co-founder and board member of WntResearch AB ("WntResearch" or the "Company"), has applied for subscription of additional units in the rights issue that was announced through a press release on 20 November 2023 (the "Rights Issue"). In addition, several of the Company's existing larger shareholders have also announced their intention to subscribe for more units than what they have committed to in advance by agreement.Tommy Andersson has, through a company and without the support of unit rights, applied for additional subscription of units in the Rights Issue with SEK 118,

Skanska builds power projects in Vestland County, Norway, for NOK 1.9 billion, about SEK 1.9 billion

Skanska has signed a contract with Aker BP for the construction of a transformer station and a compensation station in Vestland County, Norway. The contract is worth NOK 1.9 billion, about SEK 1.9 billion, which will be included in the Nordic order bookings for the first quarter 2024.The contract consists of both building and construction work related to a new transformer station in Børdalen in Samnanger municipality, as well as a compensation station at Årskog in Fitjar municipality. The construction works is ongoing, and the project is expected to be completed during the autumn 2025.

Uniwater acquires Lauridsen – expands in water and wastewater sector in the Danish market

Uniwater, the Nordic water and wastewater infrastructure group, has acquired Danish water and wastewater specialist Lauridsen. Lauridsen has operations in Denmark and Poland and an experienced team of water infrastructure specialists in both markets. The acquisition strengthens Uniwater’s expertise and presence on the Nordic and European markets.Uniwater, today consisting of 13 companies in Sweden, Norway and Finland, today announced the acquisition of Lauridsen, one of Denmark’s leading suppliers of components, technical solutions and consultancy services within water and wastewater

Norse Atlantic ASA: Last day of the subscription period in the subsequent offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Arendal, 24 January 2024: Reference is made to the stock exchange announcement published by Norse Atlantic ASA (the "Company") on 11 January 2024 regarding the approval and publication of the Prospectus (as defined below), and the launch of the

Insider Information: Pihlajalinna writes down its receivables from previous years and provides preliminary information for 2023 results

Pihlajalinna Plc             Insider Information             24 January 2024 at 8:30 a.m.  Insider Information: Pihlajalinna writes down its receivables from previous years and provides preliminary information for 2023 results  Pihlajalinna Plc specified its outlook for the year 2023 on 3 November 2023 concerning items that may, according to the management’s estimate, influence the profitability of complete outsourcing agreements with a delay. As a result of the establishment of the wellbeing services counties, Pihlajalinna aimed to finalise the negotiations related to open

Japan’s largest airline, All Nippon Airways (ANA) to establish at Stockholm Arlanda Airport – will launch direct route to Tokyo

Japan’s largest airline, ANA, will establish at Stockholm Arlanda Airport with a direct route to the country’s major hub, Tokyo Haneda. ANA will be an important addition to Stockholm Arlanda, connecting the Swedish capital with one of the most important markets in Asia.ANA (All Nippon Airways), a member of Star Alliance and the largest provider of scheduled passenger services on the domestic and international market to and from Japan, will establish at Stockholm Arlanda Airport with a direct route to Tokyo Haneda ahead of the 2024 winter schedule. The route will not only serve as an

Key information relating to the proposed cash dividend to be paid by Gjensidige Forsikring ASA

Dividend amount: NOK 8.75 per share Declared currency: NOK Last day including right: 20 March 2024 Ex-date: 21 March 2024 Record date: 22 March 2024 Payment date: 5 April 2024 Date of approval: 20 March 2024 Other information: Total amount of the proposed dividend NOK 4,375 million. This information is published in accordance with the requirements of Oslo Børs' Continuing Obligations. Contact persons Gjensidige Forsikring ASA: Head of Investor Relations: Mitra H. Negård, Tel: +47 957 93 631 Investor Relations Officer: Marius M. Fjellbo, Tel: +47 995 67 593

Results for the quarter and the full year impacted by challenging weather conditions

This release contains inside information related to Gjensidige Forsikring ASA pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act. Gjensidige generated a profit after tax of NOK 1.1 billion during the fourth quarter and NOK 4.1 billion for the full year, reflecting continued strong momentum in revenue growth, but also higher claims costs impacted by challenging weather conditions. The financial result from investments reflects the positive development in the capital markets. Gjensidige will

Swedbank’s Year-end report 2023

Swedbank´s President and CEO Jens Henriksson comments: ”Swedbank stands strong in turbulent times”.· Increased income during the year  · Good cost control – C/I ratio 0.33   · Solid credit quality in a weaker economy  · Strong capitalisation and liquidity · Swedbank 15/25 – we are delivering on the strategic plan of a sustainable return on equity of at least 15 per cent by 2025 · Proposed dividend of SEK 15.15 per share Contact:Annie Ho (annie.ho@swedbank.se), Head of Investor Relations, +46 70 343 7815Hannes Mård (hannes.mard@swedbank.se), Media Relations

Handelsbanken: Swedish economy set to grow in 2025

Real wages will start to increase this year and the Riksbank will initiate rate cuts. However, fiscal policy will not become more expansionary and the Swedish economy will not start to really take off until 2025, when inflation is finally under control. "It's going to be another tough year, but then things should ease. We expect the budget for 2025 will contain reforms of around SEK 70bn, with more money allocated to the municipalities, public investments and households", says Christina Nyman, Chief Economist at Handelsbanken. According to Handelsbanken's latest economic forecast,

There are no items matching the current filter
There are no more items matching the current filter
Back to top